Profile	GDS4460 / 206714_at
Title	Pimecrolimus and betamethasone valerate effects on lesional skin of actopic dermatitis
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM803586	patient 6, baseline	65.2	62
GSM803589	patient 7, baseline	40.7	52
GSM803592	patient 8, baseline	184.9	77
GSM803595	patient 10, baseline	752.7	94
GSM803598	patient 11, baseline	143.4	74
GSM803601	patient 12, baseline	75.6	63
GSM803604	patient 13, baseline	119.7	71
GSM803607	patient 14, baseline	102.4	68
GSM803610	patient 15, baseline	86.4	66
GSM803613	patient 16, baseline	204.3	79
GSM803587	patient 6, arm treated with pimecrolimus	98.4	68
GSM803590	patient 7, arm treated with pimecrolimus	52.8	57
GSM803593	patient 8, arm treated with pimecrolimus	72.4	62
GSM803605	patient 13, arm treated with pimecrolimus	71.2	63
GSM803608	patient 14, arm treated with pimecrolimus	91.2	67
GSM803599	patient 11, arm treated with pimecrolimus	116.1	71
GSM803611	patient 15, arm treated with pimecrolimus	80.4	64
GSM803614	patient 16, arm treated with pimecrolimus	177.2	77
GSM803602	patient 12, arm treated with pimecrolimus	24.7	39
GSM803596	patient 10, arm treated with pimecrolimus	723.2	94
GSM803591	patient 8, arm treated with betamethasone	156.5	75
GSM803609	patient 15, arm treated with betamethasone	57.8	56
GSM803597	patient 11, arm treated with betamethasone	366.5	87
GSM803585	patient 6, arm treated with betamethasone	40.1	49
GSM803603	patient 13, arm treated with betamethasone	605.9	92
GSM803612	patient 16, arm treated with betamethasone	244.2	81
GSM803588	patient 7, arm treated with betamethasone	88.9	64
GSM803594	patient 10, arm treated with betamethasone	1841.3	98
GSM803600	patient 12, arm treated with betamethasone	43.5	51
GSM803606	patient 14, arm treated with betamethasone	92	66